Related Experiment Video
Updated: Jun 3, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
S100A8 cellular distribution in normal epithelium, hyperplasia, dysplasia and squamous cell carcinoma and its
Oliver Driemel1, Niko Escher, Günther Ernst
1Department of Oral and Maxillofacial Surgery, University of Regensburg, Regensburg, Germany.
Objective:
To investigate the function of S100A8, a member of the calcium-binding S100 protein family, in oral tumorigenesis. We analyzed its cellular distribution and its serum level in patients with squamous cell carcinoma and normal controls.
Study Design:
We investigated the histopathologic features by tissue microarrays (TMAs) including 8 normal, 66 hyperplastic and dysplastic and 26 oral squamous cell carcinoma (OSCC) tissue cores. The serum level of S100A8 was measured by an enzyme-linked immunosorbent assay using 33 healthy volunteers, 20 patients with hyperproliferative lesions and 23 patients with OSCC.
Results:
The TMA analysis resulted in different findings. The strongest expression of S100A8 was found in severe dysplasias and carcinoma in situ. In tumor tissue an increased expression occurred only focally. In the normal tissue cores the epithelium showed a moderate reaction, but basal and parabasal cells were completely negative. The serum levels of S100A8 were marginally reduced in cancer patients. The expression between healthy controls and patients with hyperproliferative lesions displayed no difference.
Conclusion:
The expression of S100A8 is helpful only in the transition from severe dysplastic tissue to cancer.
More Related Videos
Related Concept Videos
Cellular Adaptation IV: Dysplasia and Metaplasia
Abnormal Proliferation
Abnormal Proliferation
Cellular Adaptation III: Hyperplasia
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

